Latest Insider Transactions at Heska Corp (HSKA)
This section provides a real-time view of insider transactions for Heska Corp (HSKA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HESKA CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HESKA CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 14
2021
|
Kevin S. Wilson CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,625
+5.91%
|
-
|
|
Jan 11
2021
|
Joachim A. Hasenmaier |
BUY
Grant, award, or other acquisition
|
Direct |
235
+50.0%
|
-
|
|
Dec 31
2020
|
Kevin S. Wilson CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,194
-1.4%
|
$173,130
$145.65 P/Share
|
|
Dec 31
2020
|
Kevin S. Wilson CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
4,119
+4.62%
|
-
|
|
Dec 28
2020
|
Nancy Wisnewski Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+10.37%
|
$24,000
$4.96 P/Share
|
|
Dec 09
2020
|
Nancy Wisnewski Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
500
-0.54%
|
$70,000
$140.42 P/Share
|
|
Dec 08
2020
|
Nancy Wisnewski Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
350
-0.38%
|
$46,550
$133.15 P/Share
|
|
Dec 07
2020
|
Nancy Wisnewski Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
150
-0.32%
|
$19,650
$131.0 P/Share
|
|
Dec 01
2020
|
Kevin S. Wilson CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,631
-1.98%
|
$200,613
$123.96 P/Share
|
|
Dec 01
2020
|
Kevin S. Wilson CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,625
+6.38%
|
-
|
|
Nov 27
2020
|
Jason D Aroesty EVP, International Diagnostics |
SELL
Open market or private sale
|
Direct |
13,334
-88.37%
|
$1,693,418
$127.06 P/Share
|
|
Nov 27
2020
|
Jason D Aroesty EVP, International Diagnostics |
BUY
Exercise of conversion of derivative security
|
Direct |
13,334
+31.16%
|
$1,413,404
$106.67 P/Share
|
|
Nov 18
2020
|
Nancy Wisnewski Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
500
-1.06%
|
$64,500
$129.5 P/Share
|
|
Nov 17
2020
|
Robert L Antin |
BUY
Grant, award, or other acquisition
|
Direct |
420
+50.0%
|
-
|
|
Nov 16
2020
|
Nancy Wisnewski Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,000
-2.07%
|
$126,000
$126.5 P/Share
|
|
Nov 09
2020
|
Bonnie J. Trowbridge Director |
SELL
Open market or private sale
|
Direct |
4,917
-10.03%
|
$624,459
$127.36 P/Share
|
|
Nov 09
2020
|
Bonnie J. Trowbridge Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,917
+24.12%
|
$137,676
$28.96 P/Share
|
|
Nov 03
2020
|
Kevin S. Wilson CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,041
-2.6%
|
$236,756
$116.41 P/Share
|
|
Nov 03
2020
|
Kevin S. Wilson CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,625
+6.68%
|
-
|
|
Oct 21
2020
|
Kevin S. Wilson CEO and President |
SELL
Open market or private sale
|
Indirect |
13,421
-82.03%
|
$1,476,310
$110.0 P/Share
|
|
Oct 08
2020
|
Kevin S. Wilson CEO and President |
SELL
Open market or private sale
|
Indirect |
3,129
-18.94%
|
$341,061
$109.0 P/Share
|